학술논문
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
Document Type
Article
Author
Source
In Annals of Oncology November 2023 34(11):1047-1054
Subject
Language
ISSN
0923-7534